Epileptic seizures, recurrent cross-sensory disturbance, dizziness, diplopia, blurred vision, vertigo, gait unsteadiness, nausea, vomiting, brainstem lesions on MRI, positive serum and CSF NMDAR and MOG antibodies. This evidence concerns the gene MOG and Vertigo.